Peyton Fleagle was just a toddler when his parents first noticed itchy scales appear on his skin. Eventually, the scales covered 95% of Peyton’s body.
Fleagle, who is now 12, has a condition called X-linked ichthyosis, one of an often-disfiguring group of...
A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial.
Alopecia areata is an autoimmune disease characterized by sudden,...
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease — both the result of pioneering research by the same...
To Jodi Sherman’s way of thinking, the Hippocratic Oath’s vow of doing no harm includes doing no harm to the planet — particularly when it comes to the sea of single-use plastic flooding the health care industry.
Sherman, an associate professor of...
Nearly 30 years ago, scientists discovered a unique class of anticancer molecules in a family of bryozoans, a phylum of marine invertebrates found in tropical waters.
The chemical structures of these molecules, which consist of a dense, highly complex...
A new Yale study finds an increased risk of hospital readmission for older Americans within 180 days of undergoing major surgery — a risk that is particularly acute for individuals who are frail or have dementia.
The findings were published Feb. 28 in the...
Two Yale faculty members — a trailblazing astrophysicist and a leading immunologist — are part of Time Magazine’s 2024 list of the 100 most influential people in the world.
Priyamvada Natarajan, whose theories on the unseen forces underpinning the...
A new, Yale-led study suggests that a range of respiratory viral infections — including COVID-19 and influenza — may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
A team led by Yale’s Akiko Iwasaki and...
This story is the fourth in a series about Yale’s evolution under President Peter Salovey as he prepares to return to the faculty at the end of this month.
One recent afternoon, physicist Larry Gladney, dean of science for the Faculty of Arts and Sciences...